One of the most frequent challenges clinicians face is managing serious illness in older patients with mild cognitive impairment (MCI), a condition that affects up to 1 in 5 older Americans. The MCI DeM study is an National Institutes of Health (NIH) / National Institute on Aging (NIA)-funded R01 study that aims to compare the quality of cardiovascular disease care in adults with and without mild cognitive impairment and to determine the influence of mild cognitive impairment on patient preferences and physician recommendations for heart attack and stroke treatment. This is a multi-center, mixed methods study in collaboration with researchers from Duke University. The study involves secondary data analysis of two existing longitudinal cohorts as well as primary data collection using semi-structured interviews and surveys of patients, care partners, and physicians.
Mild cognitive impairment and receipt of treatments for acute myocardial infarction in older adults
Levine DA et al. J Gen Intern Med. 2020. 35(1):28-35. PMID: 31410812
Physician decision-making and recommendations for stroke and myocardial infarction treatments in older adults with mild cognitive impairment
Levine DA, Langa KM, Fagerlin A, et al. PLoS One. 2020 17;15(3):e0230446. PMID: 32182264/PMCID: PMC7077853
Mild cognitive impairment and receipt of procedures for acute ischemic stroke in older adults
Levine DA, et al. J Stroke Cerebrovasc Dis. 2020. In press.
The association of cognitive impairment and dementia with receipt of cataract surgery among community-dwelling US Medicare Beneficiaries
Stagg BC, Ehrlich JR, Choi H, Levine DA. JAMA Ophthalmol. 2019;137(1):114-117. PMID: 30422225